RBSC
Collapse
Announcement
Collapse
No announcement yet.
News that is not making the NEWS
Collapse
X
-
The "medical setting" referred to in USADA's announcement was the Fayetteville, Arkansas, office of Spearmon's physician since his early teen years, Dr. Mark Bonner, where Spearmon went on June 10 to seek relief from cold-like symptoms and a sore throat which Dr. Bonner diagnosed as "seasonal allergies complicated with pharyngitis or sinusitis."
Bonner told T&FN via email that he treated the sprinter's condition with "an intramuscular injection of cortisone (a medical grade nontestosterone steroid)… along with an antibiotic for infection."
http://trackandfieldnews.com/index.p...rticle&id=2082
Leave a comment:
-
News that is not making the NEWS
September 19, 2014
USADA announced today that Wallace Spearmon, Jr., of Fayetteville, Ark., an athlete in the sport of track & field, has tested positive for a prohibited substance and accepted a three-month sanction for his rule violation.
Spearmon, 29, tested positive for Methylprednisolone as the result of an in-competition urine sample collected at the Edmonton International Track Classic on July 6, 2014. Methylprednisolone is a glucocorticosteroid prohibited in-competition under the USADA Protocol for Olympic and Paralympic Movement Testing (the “Protocol”) and the International Association of Athletics Federations (“IAAF”) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency (“WADA”) Prohibited List. Glucocorticosteroids are classified as a Specified Substance, and therefore the presence of Methylprednisolone in an athlete’s sample can result in a reduced sanction.
http://www.usada.org/us-track-field-...ule-violation/
The JAAA needs to take a page out of US Track & Field in how to protect their athletes.Tags: None
Leave a comment: